FDA Inspection 883573 — Carter BloodCare - Tyler

Carter BloodCare - Tyler — FEI 1672331

The FDA completed an inspection of Carter BloodCare - Tyler on June 6, 2014 in Tyler, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 6, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tyler, TX (United States)